Attached files

file filename
EX-23.1 - EX-23.1 - SCYNEXIS INCd914560dex231.htm

Registration No. 333-                

As filed with the Securities and Exchange Commission on April 22, 2015

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

SCYNEXIS, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware 2834 56-2181648

(State or other jurisdiction of

Incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification No.)

3501 C Tricenter Boulevard

Durham, North Carolina 27713

(919) 544-8600

(Address, including zip code and telephone number, of Registrant’s principal executive offices)

 

 

Marco Taglietti, M.D.

Chief Executive Officer

SCYNEXIS, Inc.

3501 C Tricenter Boulevard

Durham, North Carolina 27713

(919) 544-8600

(Name, address, including zip code and telephone number, including area code, of agent for service)

 

 

Copies to:

 

Matthew B. Hemington

Brett D. White

Cooley LLP

3175 Hanover Street

Palo Alto, California 94304

(650) 843-5000

 

Charles F. Osborne

Chief Financial Officer

SCYNEXIS, Inc.

3501 C Tricenter Boulevard

Durham, North Carolina 27713

(919) 544-8600

 

Curtis L. Mo

Torrie C. Nute

DLA Piper LLP (US)

2000 University Avenue

East Palo Alto, California 94303

(650) 833-2000

 

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box.  ¨

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  x  (File No. 333-203314)

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   x

The registrant is an “emerging growth company” as defined in Section 2(a) of the Securities Act. This registration statement complies with the requirements that apply to an issuer that is an emerging growth company.

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Each Class of

Securities to be Registered

 

Proposed

Maximum

Aggregate

Offering Price(1)

 

Amount of

Registration Fee(1)

Common Stock, $0.0001 par value per share

  $6,899,990   $802

 

 

(1) The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). The registrant previously registered securities at an aggregate offering price not to exceed $34,500,000 on a Registration Statement on Form S-1 (File No. 333-203314), which was declared effective by the Securities and Exchange Commission on April 22, 2015. Includes the aggregate offering price of shares that the underwriters have the option to purchase.

 

 

This Registration Statement shall become effective upon filing in accordance with Rule 462(b) under the Securities Act of 1933.

 

 

 


EXPLANATORY NOTE AND INCORPORATION OF

CERTAIN INFORMATION BY REFERENCE

This Registration Statement on Form S-1 (this “462(b) Registration Statement”) is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, solely for the purpose of registering an increase in the maximum aggregate offering price of $6,899,990. This 462(b) Registration Statement relates to the public offering of shares of common stock contemplated by the Registration Statement on Form S-1 (File No. 333-203314), which was initially filed on April 9, 2015, and which, as amended, was declared effective by the Securities and Exchange Commission on April 22, 2015. Pursuant to Rule 462(b), the contents of the Registration Statement on Form S-1 (File No. 333-203314), including the exhibits thereto, are hereby incorporated by reference into this 462(b) Registration Statement.

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 16. Exhibits and Financial Statement Schedules.

 

  (a) Exhibits

The exhibits to the registration statement are listed in the Exhibit Index attached hereto and incorporated by reference herein.

 

  (b) Financial Statements Schedules:

No financial statement schedules are provided, because the information called for is not required or is shown either in the financial statements or the notes thereto.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Durham, State of North Carolina, on April 22, 2015.

 

SCYNEXIS, INC.
By:  

/s/ Marco Taglietti, M.D.

  Marco Taglietti, M.D.
  Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Marco Taglietti, M.D.

Marco Taglietti, M.D.

   Chief Executive Officer and Director (Principal Executive Officer)   April 22, 2015

/s/ Charles F. Osborne, Jr.

Charles F. Osborne, Jr.

   Chief Financial Officer (Principal Financial and Accounting Officer)   April 22, 2015

*.

Pamela J. Kirby, Ph.D.

   Chairman of the Board of Directors   April 22, 2015

*

Yves J. Ribeill, Ph.D.

   President and Director   April 22, 2015

*

Laurent Arthaud

   Director   April 22, 2015

*

Steven C. Gilman, Ph.D.

   Director   April 22, 2015

*

Ann F. Hanham, Ph.D.

   Director   April 22, 2015

*

Patrick J. Langlois, Ph.D.

   Director   April 22, 2015

*

Guy Macdonald

   Director   April 22, 2015

*

Jean-Yves Nothias, Ph.D.

   Director   April 22, 2015

*.

Edward E. Penhoet, Ph.D.

   Director   April 22, 2015

 

* Pursuant to Power of Attorney

 

By:  

/s/ Charles F. Osborne, Jr.

 

Charles F. Osborne, Jr.

Attorney-in-fact


EXHIBIT INDEX

 

Exhibit

Number

  

Description

  5.1    Opinion of Cooley LLP (incorporated by reference and filed with the SEC as Exhibit 5.1 to our Form S-1, filed with the SEC on April 20, 2015, SEC File No. 333-203314).
23.1    Consent of Independent Registered Public Accounting Firm.
23.2    Consent of Cooley LLP (incorporated by reference and filed with the SEC as Exhibit 23.2 to our Form S-1, filed with the SEC on April 20, 2015, SEC File No. 333-203314).
24.1    Power of Attorney (incorporated by reference and filed with the SEC as Exhibit 24.1 to our Form S-1, filed with the SEC on April 20, 2015, SEC File No. 333-203314).